Fundraising Fox
Legend Biotech
NASDAQ: LEGNSomerset, US · Founded 2015 · Cayman Islands corporation · 2,611 employees on LinkedIn · 2 known investors
Find your way into Legend Biotech
Sign up to see every warm intro you have to Legend Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Legend Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Legend Biotech is a biotechnology company. The provided page content is an external-link disclaimer and contains no substantive information about the company's products or business.
Founders & leadership
YX
Yuan Xu, Ph.D.Executive
YH
Ying Huang, Ph.D.Executive
FZ
Fangliang Zhang, Ph.D.Named on SEC filing
YW
Ye Wang, M.S.Named on SEC filing
IZ
Ingrid ZhangChief Executive Officer
Investors · 2
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$350.5M disclosed across 2 rounds · 2020–2023
▶$200MraisedApr 2023 · 1 investors · BiotechnologyRule 506(b)
▶$200MraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Li Mao, MDDirector
- Tomas HeymanDirector
- Fangliang Zhang, Ph.D.Director
- Darren Xiaohui Ji, M.D., Ph.D.Director
- Li Zhu, Ph.D.Director
- Lori MacomberExecutive Officer
- Patrick Casey, Ph.D.Director
- Ye Wang, M.S.Director
- Philip Wai Man Yau, CPADirector
- Ying Huang, Ph.D.Executive Officer, Director
- Corazon D. Sanders, Ph.D.Director
- Offering amount
- $200M
- Amount sold
- $200M
- First sale
- Apr 2023
- Incorporated
- Corporation, Cayman Islands
- Federal exemptions
- 06b
▶$150.4MraisedApr 2020 · 8 investors · BiotechnologyRule 506(b)
▶$150.4MraisedApr 2020 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Fangliang Zhang, Ph.D.Director
- Yuan Xu, Ph.D.Executive Officer, Director
- Ying Huang, Ph.D.Executive Officer
- Ye Wang, M.S.Director
- Offering amount
- $160.4M
- Amount sold
- $150.4M
- First sale
- Mar 2020
- Incorporated
- Corporation, Cayman Islands, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Johnson & JohnsonJohnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision. Its two main businesses, Innovative Medicine and MedTech, focus on treating complex diseases through science-based drugs and less invasive, personalized medical devices.
AmgenAmgen is an independent biotechnology company that uses science and technology, including machine learning and human genetic data, to research and develop treatments for serious diseases such as cancer, heart disease, asthma, and osteoporosis. Its Danish operation, Amgen Danmark, focuses on improving health outcomes for patients and their families in Denmark.
Companies working in the same space as Legend Biotech.
Frequently asked questions
- What does Legend Biotech do?
- Legend Biotech is a biotechnology company. The provided page content is an external-link disclaimer and contains no substantive information about the company's products or business.
- Who are Legend Biotech's investors?
- Legend Biotech's investors include LAV, Lilly Asia Ventures.
- How much funding has Legend Biotech raised?
- Legend Biotech has disclosed $350.5M raised across 2 rounds.
- Where is Legend Biotech headquartered?
- Legend Biotech is headquartered in Somerset, US.